Mounjaro is not formally classified as a specialty drug by major pharmacy benefit managers. It is available at standard retail pharmacies, not restricted to specialty pharmacy distribution. However, it shares several characteristics with specialty medications, including refrigeration requirements, high cost, and prior authorization hurdles, which is likely why the question comes up so often.
How Mounjaro Is Classified by Insurers
Specialty drugs are typically defined by a combination of factors: high cost (often above $1,000 per month), special handling or storage needs, limited distribution networks, and requirements for ongoing clinical monitoring. Mounjaro checks some of those boxes but not all of them. CVS Specialty’s pharmacy distribution drug list does not include Mounjaro, meaning it flows through regular retail pharmacy channels rather than requiring a specialty pharmacy to dispense it.
On CVS Caremark formularies, Mounjaro sits at tier 2, which is a preferred brand tier. That’s actually a more favorable placement than many people expect. By comparison, some true specialty drugs land on tier 4 or tier 5, where copays can reach hundreds of dollars per fill. Tier 2 placement means your copay for Mounjaro will generally be lower than it would be for a specialty-tier medication, though the exact amount depends on your specific plan.
Why It Feels Like a Specialty Drug
Even though Mounjaro isn’t technically a specialty medication, the experience of getting it can feel like one. The biggest reason is prior authorization. Most insurers require documentation before they’ll approve coverage, and the criteria can be strict. The VA system, for example, requires a diagnosis of type 2 diabetes, inadequate blood sugar control on at least one other injectable plus two or more additional diabetes medications for at least six months, and proof that you’ve been consistently refilling your current prescriptions. If you’ve been on an older injectable in the same drug class, your insurer may require you to try alternatives before approving Mounjaro.
There are also storage requirements that mirror specialty medications. Unused pens must be kept refrigerated between 2°C and 8°C (about 36°F to 46°F). Once you start using a pen, it can be stored at room temperature up to 30°C (86°F), but it should always be protected from light and never frozen. During travel, Lilly recommends keeping the pen in carry-on luggage because cargo hold temperatures can swing too high or too low. These cold-chain handling needs are one of the hallmarks insurers use when deciding whether a drug qualifies as specialty, though Mounjaro’s requirements are simpler than those of many biologics that need continuous refrigeration or special reconstitution.
The Prior Authorization Process
Getting approved for Mounjaro typically involves your doctor submitting clinical documentation to your insurer. The specifics vary by plan, but common requirements include proof of a type 2 diabetes diagnosis, evidence that cheaper medications haven’t been sufficient, and recent lab results showing your blood sugar levels. Some plans also require a recent eye exam on file before approval, since rapid improvements in blood sugar can occasionally affect diabetic eye conditions.
Step therapy is another common barrier. This means your insurer wants to see that you’ve tried and either failed or couldn’t tolerate other medications before moving to Mounjaro. In practice, this often means trying a different injectable in the same class first. The VA’s criteria specifically require a trial of semaglutide injection before considering Mounjaro, and even patients who couldn’t tolerate semaglutide are asked to try yet another option in the same drug class before approval.
If you’re prescribed Mounjaro for type 2 diabetes, you’re more likely to get coverage than if the goal is weight loss alone. Insurance plans generally distinguish between the diabetes indication (covered under the Mounjaro brand) and weight loss (covered under the Zepbound brand, which is the same active ingredient but approved specifically for weight management).
Monitoring Requirements
Specialty drugs often come with mandatory check-ins from a specialty pharmacist or nurse. Mounjaro doesn’t have that formal requirement, but clinical guidelines do call for regular follow-up during and after the dose escalation period. Your diabetes care team will typically monitor whether the medication is working, with benchmarks like at least 5% body weight reduction or a meaningful improvement in blood sugar levels within six months. If those targets aren’t met, guidelines recommend discontinuing the medication rather than continuing indefinitely.
This level of monitoring is less intensive than what’s required for true specialty drugs like infusion biologics or cancer therapies, where pharmacists track side effects and lab work on a scheduled basis. With Mounjaro, routine diabetes monitoring and periodic office visits are generally sufficient.
Medicare Coverage Changes in 2026
For Medicare beneficiaries, coverage for GLP-1 medications is evolving. Starting July 2026, CMS is launching the Medicare GLP-1 Bridge program, which will cover certain GLP-1 drugs for weight loss outside of the standard Part D benefit. The eligible medications for this program are Zepbound, Wegovy, and Foundayo, specifically when prescribed for weight reduction. Mounjaro itself is not listed as an eligible drug under this bridge program, since it is approved for type 2 diabetes rather than weight management.
If you’re on Medicare and using Mounjaro for diabetes, your coverage still runs through your Part D plan’s existing formulary. If your doctor prescribes Zepbound (the same active ingredient) for an approved Part D indication like obstructive sleep apnea in adults with obesity, that would also stay under Part D rather than shifting to the bridge program. The bridge is designed exclusively for weight loss prescriptions, and CMS has said it will monitor plans to make sure they aren’t pushing patients from standard Part D coverage into the bridge to avoid costs.
Where You Can Fill Your Prescription
Because Mounjaro is not on specialty pharmacy distribution lists, you can fill it at any retail pharmacy that carries it: CVS, Walgreens, Walmart, independent pharmacies, and mail-order services. You don’t need to use a specialty pharmacy, wait for home delivery from a restricted distributor, or coordinate with a specialty pharmacist for dispensing. This is one of the clearest practical differences between Mounjaro and true specialty medications, which often can only be obtained through a handful of designated pharmacies.
That said, some insurance plans may steer you toward preferred pharmacies or mail-order options for cost savings. If your plan offers a lower copay through mail order, that’s worth considering, especially since Mounjaro pens can be stored in the refrigerator for the duration of a 90-day supply.